Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001209191-23-000956

Options or other derivatives

  • President & CEO acquired 472,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Warmuth Markus · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-03 Grant or award : show line 1 in the form Stock Option (Right to Buy) +472,000 472,000 D
Loading xslF345X03/doc4.xml…